- Home
- CVAC vs MGIC Comparison
CVAC vs MGIC Comparison
Compare CVAC & MGIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- MGIC
- Stock Information
- Founded
- CVAC 2000
- MGIC 1983
- Country
- CVAC Germany
- MGIC Israel
- Employees
- CVAC N/A
- MGIC N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- MGIC Computer Software: Prepackaged Software
- Sector
- CVAC Health Care
- MGIC Technology
- Exchange
- CVAC Nasdaq
- MGIC Nasdaq
- Market Cap
- CVAC 764.4M
- MGIC 788.0M
- IPO Year
- CVAC 2020
- MGIC 1991
- Fundamental
- Price
- CVAC $5.40
- MGIC $20.33
- Analyst Decision
- CVAC Hold
- MGIC Buy
- Analyst Count
- CVAC 3
- MGIC 2
- Target Price
- CVAC $6.83
- MGIC $16.00
- AVG Volume (30 Days)
- CVAC 2.1M
- MGIC 63.9K
- Earning Date
- CVAC 08-14-2025
- MGIC 08-13-2025
- Dividend Yield
- CVAC N/A
- MGIC 2.81%
- EPS Growth
- CVAC N/A
- MGIC 1.33
- EPS
- CVAC 0.87
- MGIC 0.76
- Revenue
- CVAC $566,039,775.00
- MGIC $569,136,000.00
- Revenue This Year
- CVAC N/A
- MGIC $7.53
- Revenue Next Year
- CVAC $24.04
- MGIC $8.96
- P/E Ratio
- CVAC $6.22
- MGIC $25.88
- Revenue Growth
- CVAC 787.60
- MGIC 6.37
- 52 Week Low
- CVAC $2.37
- MGIC $9.64
- 52 Week High
- CVAC $5.72
- MGIC $20.44
- Technical
- Relative Strength Index (RSI)
- CVAC 64.78
- MGIC 84.55
- Support Level
- CVAC $5.33
- MGIC $17.93
- Resistance Level
- CVAC $5.58
- MGIC $18.26
- Average True Range (ATR)
- CVAC 0.12
- MGIC 0.43
- MACD
- CVAC -0.04
- MGIC 0.30
- Stochastic Oscillator
- CVAC 23.81
- MGIC 97.97
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About MGIC Magic Software Enterprises Ltd.
Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. The company generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel, Europe, Japan, and Other countries.